Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices 38709 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Aging; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Board of Scientific 

Counselors, NIA. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

NATIONAL INSTITUTE ON AGING, 

including consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, NIA. 

Date: October 9, 2018. 

Time: October 9, 2018, 8:00 a.m. to 8:20 

a.m. 

Agenda: To review and evaluate personnel 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes on Aging, 

Biomedical Research Center, 3rd Floor 

Conference Room 03C227, 251 Bayview 

Boulevard, Baltimore, MD. 

Time: October 9, 2018, 8:20 a.m. to 10:50 

a.m. 

Agenda: Committee discussion, individual 

presentations, laboratory overview. 

Place: National Institutes on Aging, 

Biomedical Research Center, 3rd Floor 

Conference Room 03C227, 251 Bayview 

Boulevard, Baltimore, MD. 

Time: October 9, 2018, 10:50 a.m. to 11:05 

a.m. 

Agenda: To review and evaluate personnel 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes on Aging, 

Biomedical Research Center, 3rd Floor 

Conference Room 03C227, 251 Bayview 

Boulevard, Baltimore, MD. 

Time: October 9, 2018, 11:05 a.m. to 11:30 

a.m. 

Agenda: To review and evaluate personnel 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes on Aging, 

Biomedical Research Center, 3rd Floor 

Conference Room 03C227, 251 Bayview 

Boulevard, Baltimore, MD. 

Time: October 9, 2018, 11:30 a.m. to 2:30 

p.m. 

Agenda: To review and evaluate personnel 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes on Aging, 

Biomedical Research Center, 3rd Floor 

Conference Room 03C227, 251 Bayview 

Boulevard, Baltimore, MD. 

Time: October 9, 2018, 2:30 p.m. to 5:10 

p.m. 

Agenda: To review and evaluate personnel 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes on Aging, 

Biomedical Research Center, 3rd Floor 

Conference Room 03C227, 251 Bayview 

Boulevard, Baltimore, MD. 

Time: October 9, 2018, 5:10 p.m. to 6:10 

p.m. 

Agenda: To review and evaluate personnel 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes on Aging, 

Biomedical Research Center, 3rd Floor 

Conference Room 03C227, 251 Bayview 

Boulevard, Baltimore, MD. 

Contact Person: Luigi Ferrucci, Ph.D., MD, 

Scientific Director, National Institute on 

Aging, 251 Bayview Boulevard, Suite 100, 

Room 4C225, Baltimore, MD 21224, 410– 

558–8110, LF27Z@NIH.GOV. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: August 1, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16785 Filed 8–6–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Metformin 

and Aging. 

Date: September 12, 2018. 

Time: 2:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, Suite 2W–200, 7201 

Wisconsin Avenue, Bethesda, MD 20892. 

Contact Person: Anita H. Undale, Ph.D., 

MD, Scientific Review Branch, National 

Institute on Aging, Gateway Building, Suite 

2W200, 7201 Wisconsin Avenue, Bethesda, 

MD 20892, 240–747–7825, anita.undale@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: August 1, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16786 Filed 8–6–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID SBIR Phase II 

Clinical Trial Implementation Cooperative 

Agreement Applications (U44). 

Date: August 22, 2018. 

Time: 9:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Priti Mehrotra, Ph.D., 

Chief, Immunology Review Branch, Scientific 

Review Program, Division of Extramural 

Activities, Room #3G40 National Institutes of 

Health/NIAID, 5601 Fishers Lane, MSC 9823, 

Bethesda, MD 20892–7616, 240–669–5066, 

pmehrotra@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Clinical Trial 


daltland on DSKBBV9HB2PROD with NOTICES